Details of the Drug Combinations

General Information of This Drug (ID: DMC3P45)

Drug Name

Terameprocol DMC3P45

Synonyms

EM-1421; Terameprocol (INN/USAN); Meso-Tetra-O-methylnordihydroguaiaretic acid; Meso-Tetramethoxy-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol; Meso-1,4-Bis-(3,4-dimethoxyphenyl)-2,3-dimethylbutane; 4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

825 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole + Terameprocol	DCBQGL5	1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
10-hydroxycamptothecin + Terameprocol	DCBTSP9	10-hydroxycamptothecin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
ABIRATERONE + Terameprocol	DC5446Y	ABIRATERONE	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
ABIRATERONE + Terameprocol	DCDOT6F	ABIRATERONE	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
ABIRATERONE + Terameprocol	DC0XUK7	ABIRATERONE	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
ABIRATERONE + Terameprocol	DCNHKCN	ABIRATERONE	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
ABIRATERONE + Terameprocol	DC8Z38C	ABIRATERONE	Adenocarcinoma (Cell Line: DU-145)	[4]
ABIRATERONE + Terameprocol	DCSSIRZ	ABIRATERONE	Adenocarcinoma (Cell Line: HCT116)	[4]
ABIRATERONE + Terameprocol	DCZQLF8	ABIRATERONE	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
ABIRATERONE + Terameprocol	DCNYSY3	ABIRATERONE	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
ABIRATERONE + Terameprocol	DC5I5LR	ABIRATERONE	Lung adenocarcinoma (Cell Line: EKVX)	[4]
ABIRATERONE + Terameprocol	DC5UWPI	ABIRATERONE	Melanoma (Cell Line: SK-MEL-2)	[4]
ABIRATERONE + Terameprocol	DC2VEVL	ABIRATERONE	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
ABIRATERONE + Terameprocol	DCTXO9W	ABIRATERONE	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Acamprosate + Terameprocol	DCV99L4	Acamprosate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Acetohydroxamic Acid + Terameprocol	DCWGU47	Acetohydroxamic Acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Amiloride + Terameprocol	DCJ4SVW	Amiloride	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Aminosalicylic acid + Terameprocol	DCG5BFS	Aminosalicylic acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Amonafide + Terameprocol	DCFVBUO	Amonafide	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[3]
Anastrozole + Terameprocol	DCELYJ3	Anastrozole	Adenocarcinoma (Cell Line: DU-145)	[2]
Anastrozole + Terameprocol	DC7J5TC	Anastrozole	Adenocarcinoma (Cell Line: OVCAR3)	[2]
Anastrozole + Terameprocol	DCS3R8H	Anastrozole	Adenocarcinoma (Cell Line: NCIH23)	[2]
Anastrozole + Terameprocol	DCH2JHS	Anastrozole	Adenocarcinoma (Cell Line: SW-620)	[2]
Anastrozole + Terameprocol	DC8Z5CQ	Anastrozole	Adenocarcinoma (Cell Line: HT29)	[2]
Anastrozole + Terameprocol	DCRDJEA	Anastrozole	Adenocarcinoma (Cell Line: HCT116)	[2]
Anastrozole + Terameprocol	DCSG078	Anastrozole	Adenocarcinoma (Cell Line: HCC-2998)	[2]
Anastrozole + Terameprocol	DC8CZ5V	Anastrozole	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Anastrozole + Terameprocol	DCDJK5O	Anastrozole	Astrocytoma (Cell Line: SNB-19)	[2]
Anastrozole + Terameprocol	DC7H6YQ	Anastrozole	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Anastrozole + Terameprocol	DC7P1ER	Anastrozole	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Anastrozole + Terameprocol	DCVFJ86	Anastrozole	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Anastrozole + Terameprocol	DCFNMNJ	Anastrozole	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[2]
Anastrozole + Terameprocol	DC5V9MR	Anastrozole	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[2]
Anastrozole + Terameprocol	DCYYHHF	Anastrozole	Lung adenocarcinoma (Cell Line: HOP-62)	[2]
Anastrozole + Terameprocol	DCZN753	Anastrozole	Lung adenocarcinoma (Cell Line: EKVX)	[2]
Anastrozole + Terameprocol	DCHV865	Anastrozole	Lung adenocarcinoma (Cell Line: NCI-H522)	[2]
Anastrozole + Terameprocol	DC6F7CB	Anastrozole	Melanoma (Cell Line: UACC-257)	[2]
Anastrozole + Terameprocol	DC7ZD9Q	Anastrozole	Melanoma (Cell Line: SK-MEL-2)	[2]
Anastrozole + Terameprocol	DC7D92U	Anastrozole	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Anastrozole + Terameprocol	DC91VOU	Anastrozole	Carcinoma (Cell Line: RXF 393)	[3]
Anastrozole + Terameprocol	DCN7U0E	Anastrozole	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Anastrozole + Terameprocol	DCO56FK	Anastrozole	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Anastrozole + Terameprocol	DCL0260	Anastrozole	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Anastrozole + Terameprocol	DCC53BO	Anastrozole	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Arfolitixorin + Terameprocol	DCGX3AR	Arfolitixorin	Adenocarcinoma (Cell Line: HT29)	[4]
Armodafinil + Terameprocol	DCD5XBM	Armodafinil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Artemisinin + Terameprocol	DCTAQ37	Artemisinin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Azacitidine + Terameprocol	DCAKDEC	Azacitidine	Adenocarcinoma (Cell Line: OVCAR3)	[2]
Azacitidine + Terameprocol	DCD7SX6	Azacitidine	Adenocarcinoma (Cell Line: A549)	[2]
Azacitidine + Terameprocol	DCI9JEL	Azacitidine	Adenocarcinoma (Cell Line: HT29)	[2]
Azacitidine + Terameprocol	DCGJO6P	Azacitidine	Adenocarcinoma (Cell Line: HCT116)	[2]
Azacitidine + Terameprocol	DC9LU96	Azacitidine	Adenocarcinoma (Cell Line: HCC-2998)	[2]
Azacitidine + Terameprocol	DCRLP89	Azacitidine	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Azacitidine + Terameprocol	DCG8177	Azacitidine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[2]
Azacitidine + Terameprocol	DC4H9J4	Azacitidine	Glioma (Cell Line: SF-539)	[2]
Azacitidine + Terameprocol	DCH5ARO	Azacitidine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[2]
Azacitidine + Terameprocol	DCDGD21	Azacitidine	Lung adenocarcinoma (Cell Line: EKVX)	[2]
Azacitidine + Terameprocol	DC1K6HM	Azacitidine	Lung adenocarcinoma (Cell Line: HOP-62)	[2]
Azacitidine + Terameprocol	DCT5P2F	Azacitidine	Carcinoma (Cell Line: MCF7)	[3]
BHV-0223 + Terameprocol	DC5Z9WU	BHV-0223	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
BIO-300 + Terameprocol	DCBR77M	BIO-300	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
BIO-300 + Terameprocol	DC55UKF	BIO-300	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Bleomycin + Terameprocol	DCVQY11	Bleomycin	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Bleomycin + Terameprocol	DC4HIGA	Bleomycin	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Bleomycin + Terameprocol	DCXA9D0	Bleomycin	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Bleomycin + Terameprocol	DCTOQ9Z	Bleomycin	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Bleomycin + Terameprocol	DC3HVPY	Bleomycin	Carcinoma (Cell Line: MCF7)	[3]
Bleomycin + Terameprocol	DCXS13Y	Bleomycin	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Bleomycin + Terameprocol	DCBZ0I3	Bleomycin	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Bleomycin + Terameprocol	DC7C367	Bleomycin	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Bleomycin + Terameprocol	DCQJAN4	Bleomycin	Adenocarcinoma (Cell Line: SW-620)	[4]
Bleomycin + Terameprocol	DCBT0E3	Bleomycin	Adenocarcinoma (Cell Line: HT29)	[4]
Bleomycin + Terameprocol	DCPK2IF	Bleomycin	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Bleomycin + Terameprocol	DCTZ4HY	Bleomycin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Bleomycin + Terameprocol	DCB60Z8	Bleomycin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Bleomycin + Terameprocol	DCZ17BS	Bleomycin	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Bleomycin + Terameprocol	DCS0SMZ	Bleomycin	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Bleomycin + Terameprocol	DCMLMCS	Bleomycin	Prostate carcinoma (Cell Line: PC-3)	[4]
Bortezomib + Terameprocol	DC2D3Y2	Bortezomib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Bosentan + Terameprocol	DC4NM7D	Bosentan	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Brincidofovir + Terameprocol	DCKHTEC	Brincidofovir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Cabazitaxel + Terameprocol	DCEQQV9	Cabazitaxel	Amelanotic melanoma (Cell Line: M14)	[2]
Cabazitaxel + Terameprocol	DCBXQQZ	Cabazitaxel	Colon carcinoma (Cell Line: KM12)	[3]
Cefmenoxime + Terameprocol	DCGA0FA	Cefmenoxime	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Chloroquine + Terameprocol	DCOCNFK	Chloroquine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Cinacalcet + Terameprocol	DCG4ORR	Cinacalcet	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Clascoterone + Terameprocol	DCPIUK7	Clascoterone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Crizotinib + Terameprocol	DCULP1N	Crizotinib	Adenocarcinoma (Cell Line: OVCAR3)	[2]
Crizotinib + Terameprocol	DCETFZJ	Crizotinib	Adenocarcinoma (Cell Line: NCIH23)	[2]
Crizotinib + Terameprocol	DCU95N5	Crizotinib	Adenocarcinoma (Cell Line: HCT-15)	[2]
Crizotinib + Terameprocol	DCD9H67	Crizotinib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Crizotinib + Terameprocol	DCOL92D	Crizotinib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Crizotinib + Terameprocol	DCYXQ80	Crizotinib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[2]
Crizotinib + Terameprocol	DC2BCFJ	Crizotinib	Cutaneous melanoma (Cell Line: SK-MEL-5)	[2]
Crizotinib + Terameprocol	DCVNHXL	Crizotinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[2]
Crizotinib + Terameprocol	DC88SSR	Crizotinib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[2]
Crizotinib + Terameprocol	DCH41TQ	Crizotinib	Lung adenocarcinoma (Cell Line: HOP-62)	[2]
Crizotinib + Terameprocol	DCBHNKI	Crizotinib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[2]
Crizotinib + Terameprocol	DC47GF0	Crizotinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[2]
Crizotinib + Terameprocol	DCRP2PC	Crizotinib	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Crizotinib + Terameprocol	DC39DX3	Crizotinib	Renal cell carcinoma (Cell Line: UO-31)	[2]
Crizotinib + Terameprocol	DCN5UNA	Crizotinib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[3]
Crizotinib + Terameprocol	DC8ZOGD	Crizotinib	Carcinoma (Cell Line: RXF 393)	[3]
Crizotinib + Terameprocol	DC9MNOY	Crizotinib	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Crizotinib + Terameprocol	DCPOP0B	Crizotinib	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Crizotinib + Terameprocol	DC9V8B5	Crizotinib	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Cycloguanil + Terameprocol	DCUGQSN	Cycloguanil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Dacarbazine + Terameprocol	DC6OGN0	Dacarbazine	Adenocarcinoma (Cell Line: HT29)	[2]
Dacarbazine + Terameprocol	DC3ALZB	Dacarbazine	Adenocarcinoma (Cell Line: HCT-15)	[2]
Dacarbazine + Terameprocol	DCOH4WS	Dacarbazine	Adenocarcinoma (Cell Line: HCC-2998)	[2]
Dacarbazine + Terameprocol	DCHZOS9	Dacarbazine	Adenocarcinoma (Cell Line: HCT116)	[2]
Dacarbazine + Terameprocol	DC9JF62	Dacarbazine	Amelanotic melanoma (Cell Line: MDA-MB-435)	[2]
Dacarbazine + Terameprocol	DCAQ3KU	Dacarbazine	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Dacarbazine + Terameprocol	DCJQCW2	Dacarbazine	Colon carcinoma (Cell Line: KM12)	[3]
Dactinomycin + Terameprocol	DCQ069U	Dactinomycin	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Dactinomycin + Terameprocol	DC2GD9H	Dactinomycin	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Dactinomycin + Terameprocol	DC9O1BS	Dactinomycin	Adenocarcinoma (Cell Line: DU-145)	[4]
Dactinomycin + Terameprocol	DCHC7JO	Dactinomycin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Dactinomycin + Terameprocol	DCO0C0B	Dactinomycin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Dactinomycin + Terameprocol	DCKRPXL	Dactinomycin	Glioblastoma (Cell Line: SNB-75)	[4]
Dactinomycin + Terameprocol	DC6VOOW	Dactinomycin	Prostate carcinoma (Cell Line: PC-3)	[4]
Dactinomycin + Terameprocol	DC0C3QY	Dactinomycin	Renal cell carcinoma (Cell Line: SN12C)	[4]
Daidzin + Terameprocol	DCIU8WI	Daidzin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Dasatinib + Terameprocol	DCULAIE	Dasatinib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Dasatinib + Terameprocol	DCSRMIL	Dasatinib	Glioma (Cell Line: SF-539)	[2]
Dasatinib + Terameprocol	DCRKBPV	Dasatinib	Glioma (Cell Line: SF-295)	[2]
Dasatinib + Terameprocol	DCCHPFT	Dasatinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[2]
Dasatinib + Terameprocol	DCD9B0R	Dasatinib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[2]
Dasatinib + Terameprocol	DCX75RP	Dasatinib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[3]
Dasatinib + Terameprocol	DCGGW8T	Dasatinib	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Dexrazoxane + Terameprocol	DCP2C9O	Dexrazoxane	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Dexrazoxane + Terameprocol	DC08A6J	Dexrazoxane	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Dexrazoxane + Terameprocol	DCXB04T	Dexrazoxane	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Dexrazoxane + Terameprocol	DC5S9Q2	Dexrazoxane	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Dexrazoxane + Terameprocol	DCSVNIF	Dexrazoxane	Adenocarcinoma (Cell Line: SW-620)	[4]
Dexrazoxane + Terameprocol	DCHKJL3	Dexrazoxane	Adenocarcinoma (Cell Line: HT29)	[4]
Dexrazoxane + Terameprocol	DCW9VVX	Dexrazoxane	Adenocarcinoma (Cell Line: HCT116)	[4]
Dexrazoxane + Terameprocol	DCAXL5N	Dexrazoxane	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Dextromethorphan + Terameprocol	DCH0ZBN	Dextromethorphan	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
DFN-15 + Terameprocol	DC17SWV	DFN-15	Astrocytoma (Cell Line: U251)	[2]
DFN-15 + Terameprocol	DCUYSN2	DFN-15	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
DFN-15 + Terameprocol	DCORIMS	DFN-15	Glioma (Cell Line: SF-539)	[2]
DFN-15 + Terameprocol	DCU5KYI	DFN-15	Adenocarcinoma (Cell Line: NCIH23)	[4]
DFN-15 + Terameprocol	DC1L534	DFN-15	Adenocarcinoma (Cell Line: HCC-2998)	[4]
DFN-15 + Terameprocol	DC4NDKD	DFN-15	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[4]
DFN-15 + Terameprocol	DC69APN	DFN-15	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[4]
Diazoxide + Terameprocol	DCXT6TB	Diazoxide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Diphenidol + Terameprocol	DCZIKEX	Diphenidol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Docetaxel + Terameprocol	DC3PUJ1	Docetaxel	Adenocarcinoma (Cell Line: OVCAR3)	[2]
Docetaxel + Terameprocol	DCHJOKA	Docetaxel	Adenocarcinoma (Cell Line: HT29)	[2]
Docetaxel + Terameprocol	DCYQPW3	Docetaxel	Adenocarcinoma (Cell Line: HCT116)	[2]
Docetaxel + Terameprocol	DCQ5SJ4	Docetaxel	Adenocarcinoma (Cell Line: SW-620)	[2]
Docetaxel + Terameprocol	DCYRKUS	Docetaxel	Adenocarcinoma (Cell Line: HCC-2998)	[2]
Docetaxel + Terameprocol	DCYZQQM	Docetaxel	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Docetaxel + Terameprocol	DCR9S6N	Docetaxel	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Docetaxel + Terameprocol	DCBF7JA	Docetaxel	Amelanotic melanoma (Cell Line: M14)	[2]
Docetaxel + Terameprocol	DCV36WD	Docetaxel	Astrocytoma (Cell Line: U251)	[2]
Docetaxel + Terameprocol	DC75FRR	Docetaxel	Astrocytoma (Cell Line: SNB-19)	[2]
Docetaxel + Terameprocol	DCC1AGW	Docetaxel	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Docetaxel + Terameprocol	DC42ZJK	Docetaxel	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Docetaxel + Terameprocol	DCMCA3M	Docetaxel	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Docetaxel + Terameprocol	DC9SJ8F	Docetaxel	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Docetaxel + Terameprocol	DCUMCW8	Docetaxel	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Docetaxel + Terameprocol	DCNSAC0	Docetaxel	Cutaneous melanoma (Cell Line: SK-MEL-28)	[2]
Docetaxel + Terameprocol	DCO4RWV	Docetaxel	Glioma (Cell Line: SF-268)	[2]
Docetaxel + Terameprocol	DCEPCYB	Docetaxel	Glioma (Cell Line: SF-295)	[2]
Docetaxel + Terameprocol	DC3K2QW	Docetaxel	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[2]
Docetaxel + Terameprocol	DCEMISO	Docetaxel	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[2]
Docetaxel + Terameprocol	DCR3BJO	Docetaxel	Large cell lung carcinoma (Cell Line: NCI-H460)	[2]
Docetaxel + Terameprocol	DCX9W8D	Docetaxel	Lung adenocarcinoma (Cell Line: NCI-H522)	[2]
Docetaxel + Terameprocol	DC7R7D0	Docetaxel	Malignant melanoma (Cell Line: LOX IMVI)	[2]
Docetaxel + Terameprocol	DCZY8HZ	Docetaxel	Melanoma (Cell Line: MALME-3M)	[2]
Docetaxel + Terameprocol	DCN8G6F	Docetaxel	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[2]
Docetaxel + Terameprocol	DCGWNRT	Docetaxel	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Docetaxel + Terameprocol	DCW5A1V	Docetaxel	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Docetaxel + Terameprocol	DC0NZEH	Docetaxel	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[2]
Docetaxel + Terameprocol	DC5MWRB	Docetaxel	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[3]
Docetaxel + Terameprocol	DCJSNPD	Docetaxel	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Efavirenz + Terameprocol	DCPTDQ0	Efavirenz	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Epirubicin + Terameprocol	DC45E43	Epirubicin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Epirubicin + Terameprocol	DCYDRAP	Epirubicin	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Epirubicin + Terameprocol	DCCR3AD	Epirubicin	Astrocytoma (Cell Line: SNB-19)	[2]
Epirubicin + Terameprocol	DCT23YI	Epirubicin	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Epirubicin + Terameprocol	DCQ7X6W	Epirubicin	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Epirubicin + Terameprocol	DC698QN	Epirubicin	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Epirubicin + Terameprocol	DC1NSND	Epirubicin	Glioma (Cell Line: SF-268)	[2]
Epirubicin + Terameprocol	DC9WIVA	Epirubicin	Carcinoma (Cell Line: RXF 393)	[3]
Epirubicin + Terameprocol	DCRIOGO	Epirubicin	Carcinoma (Cell Line: MCF7)	[3]
Epirubicin + Terameprocol	DCBCMPC	Epirubicin	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Epirubicin + Terameprocol	DCUYYD8	Epirubicin	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Epirubicin + Terameprocol	DCDG6SR	Epirubicin	Adenocarcinoma (Cell Line: DU-145)	[4]
Epirubicin + Terameprocol	DCZDGFH	Epirubicin	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Epirubicin + Terameprocol	DCDN7IS	Epirubicin	Adenocarcinoma (Cell Line: NCIH23)	[4]
Epirubicin + Terameprocol	DC122YH	Epirubicin	Adenocarcinoma (Cell Line: HCT116)	[4]
Epirubicin + Terameprocol	DCV2ALU	Epirubicin	Adenocarcinoma (Cell Line: HT29)	[4]
Epirubicin + Terameprocol	DC0ZUPZ	Epirubicin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[4]
Epirubicin + Terameprocol	DC3IDWP	Epirubicin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Epirubicin + Terameprocol	DCWETAX	Epirubicin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Epirubicin + Terameprocol	DCGHDII	Epirubicin	Lung adenocarcinoma (Cell Line: EKVX)	[4]
Epirubicin + Terameprocol	DC6RZ6D	Epirubicin	Lung adenocarcinoma (Cell Line: NCI-H522)	[4]
Epirubicin + Terameprocol	DC32I6O	Epirubicin	Malignant melanoma (Cell Line: UACC62)	[4]
Epirubicin + Terameprocol	DCKC3E6	Epirubicin	Melanoma (Cell Line: SK-MEL-2)	[4]
Epirubicin + Terameprocol	DCD8F5I	Epirubicin	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Estramustine + Terameprocol	DCMLP1E	Estramustine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Estramustine + Terameprocol	DCLMFEE	Estramustine	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Estramustine + Terameprocol	DC2EM13	Estramustine	Carcinoma (Cell Line: MCF7)	[3]
Estramustine + Terameprocol	DCGHEC2	Estramustine	Colon carcinoma (Cell Line: KM12)	[3]
Estramustine + Terameprocol	DCUFW4U	Estramustine	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
Ethinyl estradiol + Terameprocol	DCHGAXG	Ethinyl estradiol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Etonogestrel + Terameprocol	DCLDQ2G	Etonogestrel	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Fenoprofen + Terameprocol	DC4RP0Q	Fenoprofen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Fludarabine + Terameprocol	DCXJ4UB	Fludarabine	Carcinoma (Cell Line: MCF7)	[3]
Fomepizole + Terameprocol	DC2FS0V	Fomepizole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
FORMESTANE + Terameprocol	DC6R6Y6	FORMESTANE	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Galantamine + Terameprocol	DC91LMR	Galantamine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Gefitinib + Terameprocol	DCKNO50	Gefitinib	Adenocarcinoma (Cell Line: SW-620)	[2]
Gefitinib + Terameprocol	DC230MQ	Gefitinib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[2]
Gefitinib + Terameprocol	DCHNVJK	Gefitinib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Gefitinib + Terameprocol	DCIW52Z	Gefitinib	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Gefitinib + Terameprocol	DCOMPEV	Gefitinib	Carcinoma (Cell Line: MCF7)	[3]
Gefitinib + Terameprocol	DC2DBFO	Gefitinib	Colon carcinoma (Cell Line: KM12)	[3]
GS4071 + Terameprocol	DCCF506	GS4071	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Hepzato + Terameprocol	DCUD1D2	Hepzato	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Hepzato + Terameprocol	DC6S3XJ	Hepzato	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Hepzato + Terameprocol	DC7DHX3	Hepzato	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Hepzato + Terameprocol	DC4XWNC	Hepzato	Astrocytoma (Cell Line: U251)	[2]
Hepzato + Terameprocol	DCFBNEA	Hepzato	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Hepzato + Terameprocol	DCK8IHH	Hepzato	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Hepzato + Terameprocol	DC74FIE	Hepzato	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Hepzato + Terameprocol	DCX12ZO	Hepzato	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Hepzato + Terameprocol	DCVMJY8	Hepzato	Glioblastoma (Cell Line: SNB-75)	[2]
Hepzato + Terameprocol	DCL6PM8	Hepzato	Glioma (Cell Line: SF-539)	[2]
Hepzato + Terameprocol	DC0HL1I	Hepzato	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Hepzato + Terameprocol	DCLI4ZC	Hepzato	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Hepzato + Terameprocol	DCFCD95	Hepzato	Carcinoma (Cell Line: RXF 393)	[3]
Hepzato + Terameprocol	DCJAFQX	Hepzato	Carcinoma (Cell Line: MCF7)	[3]
Hepzato + Terameprocol	DCHXDHA	Hepzato	Colon carcinoma (Cell Line: KM12)	[3]
Hepzato + Terameprocol	DCXSO0L	Hepzato	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Hepzato + Terameprocol	DCRLWII	Hepzato	Adenocarcinoma (Cell Line: DU-145)	[4]
Hepzato + Terameprocol	DCAOI22	Hepzato	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Hepzato + Terameprocol	DC68ZAG	Hepzato	Adenocarcinoma (Cell Line: NCIH23)	[4]
Hepzato + Terameprocol	DCZ5PNP	Hepzato	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Hepzato + Terameprocol	DCOZG66	Hepzato	Adenocarcinoma (Cell Line: HT29)	[4]
Hepzato + Terameprocol	DCOSCEX	Hepzato	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Hepzato + Terameprocol	DCMHZN5	Hepzato	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Hepzato + Terameprocol	DCO3U9J	Hepzato	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[4]
Hepzato + Terameprocol	DCH88QQ	Hepzato	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Hepzato + Terameprocol	DC7GGYG	Hepzato	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Hepzato + Terameprocol	DCGA0HM	Hepzato	Lung adenocarcinoma (Cell Line: HOP-62)	[4]
Hepzato + Terameprocol	DC4RH99	Hepzato	Lung adenocarcinoma (Cell Line: EKVX)	[4]
Hepzato + Terameprocol	DC7QPNF	Hepzato	Lung adenocarcinoma (Cell Line: NCI-H522)	[4]
Hepzato + Terameprocol	DCP7VOU	Hepzato	Malignant melanoma (Cell Line: UACC62)	[4]
Hepzato + Terameprocol	DC7ZBXV	Hepzato	Melanoma (Cell Line: UACC-257)	[4]
Hepzato + Terameprocol	DCVEPHT	Hepzato	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
Idarubicin + Terameprocol	DCXWIVI	Idarubicin	Adenocarcinoma (Cell Line: HCT116)	[4]
Idarubicin + Terameprocol	DCPGEBZ	Idarubicin	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
Idarubicin + Terameprocol	DC1ADAR	Idarubicin	Prostate carcinoma (Cell Line: PC-3)	[4]
Imatinib + Terameprocol	DCIU24C	Imatinib	Adenocarcinoma (Cell Line: NCIH23)	[2]
Imatinib + Terameprocol	DCM8K3N	Imatinib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Imatinib + Terameprocol	DCAL5PJ	Imatinib	Malignant melanoma (Cell Line: LOX IMVI)	[2]
Indazole derivative 5 + Terameprocol	DCV87W6	Indazole derivative 5	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Indazole derivative 5 + Terameprocol	DCSUAG1	Indazole derivative 5	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Indazole derivative 5 + Terameprocol	DCQNXMZ	Indazole derivative 5	Renal cell carcinoma (Cell Line: UO-31)	[2]
Indazole derivative 5 + Terameprocol	DC12K85	Indazole derivative 5	Carcinoma (Cell Line: RXF 393)	[3]
Indazole derivative 5 + Terameprocol	DCUX42S	Indazole derivative 5	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Indazole derivative 5 + Terameprocol	DC5OXWP	Indazole derivative 5	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Indazole derivative 5 + Terameprocol	DC217OB	Indazole derivative 5	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Indazole derivative 5 + Terameprocol	DC9SH51	Indazole derivative 5	Adenocarcinoma (Cell Line: DU-145)	[4]
Indazole derivative 5 + Terameprocol	DCIMZ2J	Indazole derivative 5	Adenocarcinoma (Cell Line: NCIH23)	[4]
Indazole derivative 5 + Terameprocol	DCVQ2K0	Indazole derivative 5	Adenocarcinoma (Cell Line: HT29)	[4]
Indazole derivative 5 + Terameprocol	DC0RCV4	Indazole derivative 5	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Indazole derivative 5 + Terameprocol	DCCD82J	Indazole derivative 5	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Indazole derivative 5 + Terameprocol	DCPFLPO	Indazole derivative 5	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Indazole derivative 5 + Terameprocol	DCRJ3J5	Indazole derivative 5	Lung adenocarcinoma (Cell Line: HOP-62)	[4]
Indazole derivative 5 + Terameprocol	DCRTPNL	Indazole derivative 5	Melanoma (Cell Line: SK-MEL-2)	[4]
Indazole derivative 5 + Terameprocol	DCR8L8L	Indazole derivative 5	Melanoma (Cell Line: MALME-3M)	[4]
Indazole derivative 5 + Terameprocol	DCRHAR1	Indazole derivative 5	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
Indazole derivative 5 + Terameprocol	DCWZWBU	Indazole derivative 5	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Indazole derivative 5 + Terameprocol	DCIHAEI	Indazole derivative 5	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[4]
Indazole derivative 5 + Terameprocol	DCZHKYJ	Indazole derivative 5	Prostate carcinoma (Cell Line: PC-3)	[4]
L-165041 + Terameprocol	DCSEG1N	L-165041	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Lapatinib + Terameprocol	DC6EI9S	Lapatinib	Adenocarcinoma (Cell Line: SW-620)	[4]
Lapatinib + Terameprocol	DC2QRLQ	Lapatinib	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
Lapatinib + Terameprocol	DCM0HF2	Lapatinib	Malignant melanoma (Cell Line: UACC62)	[4]
Lenalidomide + Terameprocol	DC5EXVJ	Lenalidomide	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Lenalidomide + Terameprocol	DCL8AGF	Lenalidomide	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Lenalidomide + Terameprocol	DCRL0IJ	Lenalidomide	Carcinoma (Cell Line: RXF 393)	[3]
Lenalidomide + Terameprocol	DC2V8MY	Lenalidomide	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Lenalidomide + Terameprocol	DCHVSKR	Lenalidomide	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Lenalidomide + Terameprocol	DCMQG9R	Lenalidomide	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Lenalidomide + Terameprocol	DCCW4JM	Lenalidomide	Adenocarcinoma (Cell Line: HT29)	[4]
Lenalidomide + Terameprocol	DC438Y6	Lenalidomide	Adenocarcinoma (Cell Line: HCT116)	[4]
Lenalidomide + Terameprocol	DCHRZGZ	Lenalidomide	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Lenalidomide + Terameprocol	DCQZVT6	Lenalidomide	Adenocarcinoma (Cell Line: HCT-15)	[4]
Lenalidomide + Terameprocol	DCQULVA	Lenalidomide	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Lenalidomide + Terameprocol	DCGXGNC	Lenalidomide	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Lenalidomide + Terameprocol	DCRQPXM	Lenalidomide	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Lenalidomide + Terameprocol	DCTX2L6	Lenalidomide	Lung adenocarcinoma (Cell Line: EKVX)	[4]
Lenalidomide + Terameprocol	DCV5ADR	Lenalidomide	Melanoma (Cell Line: MALME-3M)	[4]
Lenalidomide + Terameprocol	DC9YTCS	Lenalidomide	Melanoma (Cell Line: SK-MEL-2)	[4]
Lenalidomide + Terameprocol	DCMKAIP	Lenalidomide	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Letrozole + Terameprocol	DC5WIRD	Letrozole	Adenocarcinoma (Cell Line: HCT-15)	[2]
Letrozole + Terameprocol	DCEF62E	Letrozole	Adenocarcinoma (Cell Line: HCC-2998)	[2]
Letrozole + Terameprocol	DC3VAUR	Letrozole	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Letrozole + Terameprocol	DCACT2Y	Letrozole	Lung adenocarcinoma (Cell Line: EKVX)	[2]
Levamisole + Terameprocol	DCYUUS4	Levamisole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
LIAROZOLE + Terameprocol	DCVFB6N	LIAROZOLE	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
LIAROZOLE + Terameprocol	DCHAXX3	LIAROZOLE	Amelanotic melanoma (Cell Line: M14)	[4]
Linagliptin + Terameprocol	DCYXFD7	Linagliptin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Lithium Citrate + Terameprocol	DC5BSLD	Lithium Citrate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Loperamide + Terameprocol	DCS60T3	Loperamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Lubiprostone + Terameprocol	DCW2S39	Lubiprostone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Lumefantrine + Terameprocol	DCCSH5V	Lumefantrine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Mebendazole + Terameprocol	DC1XW6D	Mebendazole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Mebutamate + Terameprocol	DCIPYYH	Mebutamate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Mecamylamine + Terameprocol	DCZYI6T	Mecamylamine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Mechlorethamine + Terameprocol	DCQVOA4	Mechlorethamine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Mechlorethamine + Terameprocol	DCQXBSO	Mechlorethamine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Mechlorethamine + Terameprocol	DCDY0E5	Mechlorethamine	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Mechlorethamine + Terameprocol	DCF57TJ	Mechlorethamine	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Mechlorethamine + Terameprocol	DC7CKHE	Mechlorethamine	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Mechlorethamine + Terameprocol	DCAS6UE	Mechlorethamine	Glioblastoma (Cell Line: SNB-75)	[2]
Mechlorethamine + Terameprocol	DCIXYTE	Mechlorethamine	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Mechlorethamine + Terameprocol	DC34PQ7	Mechlorethamine	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Mechlorethamine + Terameprocol	DCVW9CP	Mechlorethamine	Adenocarcinoma (Cell Line: A549)	[4]
Mechlorethamine + Terameprocol	DCH9SFP	Mechlorethamine	Adenocarcinoma (Cell Line: HT29)	[4]
Mechlorethamine + Terameprocol	DCOK1FQ	Mechlorethamine	Adenocarcinoma (Cell Line: HCT116)	[4]
Mechlorethamine + Terameprocol	DC00D2V	Mechlorethamine	Adenocarcinoma (Cell Line: HCT-15)	[4]
Mechlorethamine + Terameprocol	DCJWEHK	Mechlorethamine	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Mechlorethamine + Terameprocol	DCHK5V5	Mechlorethamine	Lung adenocarcinoma (Cell Line: EKVX)	[4]
Mechlorethamine + Terameprocol	DCUTZLX	Mechlorethamine	Melanoma (Cell Line: SK-MEL-2)	[4]
Mesalazine + Terameprocol	DCHSV6V	Mesalazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Metyrosine + Terameprocol	DC2QI3S	Metyrosine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Miconazole + Terameprocol	DCUYP4H	Miconazole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Mycophenolic acid + Terameprocol	DC7TAH1	Mycophenolic acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Nabilone + Terameprocol	DCE2116	Nabilone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Nilotinib + Terameprocol	DCW5ZRZ	Nilotinib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Nilotinib + Terameprocol	DCUBNK6	Nilotinib	Adenocarcinoma (Cell Line: DU-145)	[4]
Nilotinib + Terameprocol	DCWSS12	Nilotinib	Malignant melanoma (Cell Line: UACC62)	[4]
Nitrosoglutathione + Terameprocol	DC9S9AK	Nitrosoglutathione	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Norcisapride + Terameprocol	DCXU3Y6	Norcisapride	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Olmesartan medoxomil + Terameprocol	DCL8I1F	Olmesartan medoxomil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Oseltamivir + Terameprocol	DC29EJB	Oseltamivir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Paromomycin + Terameprocol	DCDJ7A8	Paromomycin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Pentamidine + Terameprocol	DCQ5QN8	Pentamidine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
PFK-158 + Terameprocol	DCKCWL8	PFK-158	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Terameprocol	DCET8R2	Picoplatin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Picoplatin + Terameprocol	DC78L8J	Picoplatin	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Picoplatin + Terameprocol	DCK58TP	Picoplatin	Astrocytoma (Cell Line: U251)	[2]
Picoplatin + Terameprocol	DC84PJ5	Picoplatin	Astrocytoma (Cell Line: SNB-19)	[2]
Picoplatin + Terameprocol	DCS640N	Picoplatin	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Picoplatin + Terameprocol	DCAYZNM	Picoplatin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Picoplatin + Terameprocol	DCTWTFF	Picoplatin	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + Terameprocol	DCA9WTM	Picoplatin	Colon carcinoma (Cell Line: KM12)	[3]
Picoplatin + Terameprocol	DC06LX9	Picoplatin	Adenocarcinoma (Cell Line: HT29)	[4]
Picoplatin + Terameprocol	DC8HATX	Picoplatin	Adenocarcinoma (Cell Line: HCT-15)	[4]
Picoplatin + Terameprocol	DCSNOBC	Picoplatin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Picoplatin + Terameprocol	DCL4GX3	Picoplatin	Lung adenocarcinoma (Cell Line: NCI-H522)	[4]
Picoplatin + Terameprocol	DC7V87N	Picoplatin	Malignant melanoma (Cell Line: UACC62)	[4]
Picoplatin + Terameprocol	DCSZ3FB	Picoplatin	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Picoplatin + Terameprocol	DCOCPP3	Picoplatin	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[4]
Pinacidil + Terameprocol	DC79ATL	Pinacidil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Pizotyline + Terameprocol	DC1Q1Z2	Pizotyline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
PMID28460551-Compound-2 + Terameprocol	DCCE4GE	PMID28460551-Compound-2	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
PMID28460551-Compound-2 + Terameprocol	DCA832Q	PMID28460551-Compound-2	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
PMID28460551-Compound-2 + Terameprocol	DC6SCLI	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: HCT-15)	[4]
Primidone + Terameprocol	DC4H2X5	Primidone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Procarbazine + Terameprocol	DCHDZWU	Procarbazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Pyrazinamide + Terameprocol	DCZ2WI1	Pyrazinamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Quinine + Terameprocol	DCDC9ZH	Quinine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Raloxifene + Terameprocol	DCLIIMI	Raloxifene	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Raloxifene + Terameprocol	DC973CU	Raloxifene	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Raloxifene + Terameprocol	DCTZ0A3	Raloxifene	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Raloxifene + Terameprocol	DCWB715	Raloxifene	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Raloxifene + Terameprocol	DCERFI9	Raloxifene	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Raloxifene + Terameprocol	DCGUJFM	Raloxifene	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Raloxifene + Terameprocol	DCI7WU6	Raloxifene	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Raloxifene + Terameprocol	DCYKKU3	Raloxifene	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[4]
Raloxifene + Terameprocol	DCNVX59	Raloxifene	Malignant melanoma (Cell Line: UACC62)	[4]
Raloxifene + Terameprocol	DCNOVY2	Raloxifene	Melanoma (Cell Line: MALME-3M)	[4]
Ruxolitinib + Terameprocol	DCRLHHF	Ruxolitinib	Astrocytoma (Cell Line: U251)	[2]
Ruxolitinib + Terameprocol	DC05N6P	Ruxolitinib	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Ruxolitinib + Terameprocol	DCRBJDD	Ruxolitinib	Glioma (Cell Line: SF-268)	[2]
Ruxolitinib + Terameprocol	DC25VP5	Ruxolitinib	Carcinoma (Cell Line: MCF7)	[3]
Ruxolitinib + Terameprocol	DCRJM83	Ruxolitinib	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Ruxolitinib + Terameprocol	DCTAS8P	Ruxolitinib	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Ruxolitinib + Terameprocol	DCFMMP1	Ruxolitinib	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Ruxolitinib + Terameprocol	DC8ALQ1	Ruxolitinib	Adenocarcinoma (Cell Line: HT29)	[4]
Ruxolitinib + Terameprocol	DCKMO2D	Ruxolitinib	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Ruxolitinib + Terameprocol	DCSAVXG	Ruxolitinib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Ruxolitinib + Terameprocol	DCOBX4R	Ruxolitinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Ruxolitinib + Terameprocol	DCRJZDZ	Ruxolitinib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Ruxolitinib + Terameprocol	DCPAFLD	Ruxolitinib	Lung adenocarcinoma (Cell Line: HOP-62)	[4]
Ruxolitinib + Terameprocol	DCRW50U	Ruxolitinib	Melanoma (Cell Line: SK-MEL-2)	[4]
Ruxolitinib + Terameprocol	DC17LEH	Ruxolitinib	Melanoma (Cell Line: UACC-257)	[4]
Ruxolitinib + Terameprocol	DCHJY3R	Ruxolitinib	Melanoma (Cell Line: MALME-3M)	[4]
Ruxolitinib + Terameprocol	DCBBHLK	Ruxolitinib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Ruxolitinib + Terameprocol	DCBFI6S	Ruxolitinib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
Ruxolitinib + Terameprocol	DCXFD3Z	Ruxolitinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Ruxolitinib + Terameprocol	DC8I84W	Ruxolitinib	Prostate carcinoma (Cell Line: PC-3)	[4]
SCH 727965 + Terameprocol	DC7RJH6	SCH 727965	Astrocytoma (Cell Line: U251)	[2]
SCH 727965 + Terameprocol	DCOYWKC	SCH 727965	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
SCH 727965 + Terameprocol	DC2Y8P6	SCH 727965	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
SCH 727965 + Terameprocol	DCF38PO	SCH 727965	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
SCH 727965 + Terameprocol	DCDI8OK	SCH 727965	Glioma (Cell Line: SF-295)	[2]
SCH 727965 + Terameprocol	DCGOUB7	SCH 727965	Glioma (Cell Line: SF-268)	[2]
SCH 727965 + Terameprocol	DCMLU56	SCH 727965	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
SCH 727965 + Terameprocol	DCSMN2R	SCH 727965	Adenocarcinoma (Cell Line: HT29)	[4]
SCH 727965 + Terameprocol	DCETV9W	SCH 727965	Lung adenocarcinoma (Cell Line: EKVX)	[4]
SCH 727965 + Terameprocol	DC3WBS1	SCH 727965	Lung adenocarcinoma (Cell Line: NCI-H522)	[4]
Sirolimus + Terameprocol	DCSPGGO	Sirolimus	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Sirolimus + Terameprocol	DCC3EAT	Sirolimus	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Sirolimus + Terameprocol	DCWY3GX	Sirolimus	Glioma (Cell Line: SF-539)	[2]
Sirolimus + Terameprocol	DCKZ4GY	Sirolimus	Glioma (Cell Line: SF-295)	[2]
Sirolimus + Terameprocol	DC03ATX	Sirolimus	Carcinoma (Cell Line: MCF7)	[3]
Sirolimus + Terameprocol	DCH6Y5W	Sirolimus	Colon carcinoma (Cell Line: KM12)	[3]
Sirolimus + Terameprocol	DCBLKPP	Sirolimus	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Sirolimus + Terameprocol	DC9CTJ7	Sirolimus	Adenocarcinoma (Cell Line: HCT116)	[4]
Sirolimus + Terameprocol	DCUOZAI	Sirolimus	Amelanotic melanoma (Cell Line: M14)	[4]
Sirolimus + Terameprocol	DCICKFD	Sirolimus	Prostate carcinoma (Cell Line: PC-3)	[4]
Sorafenib + Terameprocol	DC4XF86	Sorafenib	Adenocarcinoma (Cell Line: OVCAR3)	[2]
Sorafenib + Terameprocol	DC1KTHH	Sorafenib	Adenocarcinoma (Cell Line: A549)	[2]
Sorafenib + Terameprocol	DCSB4NZ	Sorafenib	Adenocarcinoma (Cell Line: NCIH23)	[2]
Sorafenib + Terameprocol	DCNWDQS	Sorafenib	Adenocarcinoma (Cell Line: HCT116)	[2]
Sorafenib + Terameprocol	DCVFYS1	Sorafenib	Adenocarcinoma (Cell Line: HT29)	[2]
Sorafenib + Terameprocol	DCN6UR2	Sorafenib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Sorafenib + Terameprocol	DCE3M8A	Sorafenib	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Sorafenib + Terameprocol	DC6EQIF	Sorafenib	Astrocytoma (Cell Line: U251)	[2]
Sorafenib + Terameprocol	DCKTFWM	Sorafenib	Astrocytoma (Cell Line: SNB-19)	[2]
Sorafenib + Terameprocol	DCV41I2	Sorafenib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Sorafenib + Terameprocol	DCXG3M2	Sorafenib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Sorafenib + Terameprocol	DCW77OV	Sorafenib	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Sorafenib + Terameprocol	DCB8D5I	Sorafenib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Sorafenib + Terameprocol	DCFG5MD	Sorafenib	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Sorafenib + Terameprocol	DC6X7XF	Sorafenib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[2]
Sorafenib + Terameprocol	DC3WRMZ	Sorafenib	Cutaneous melanoma (Cell Line: SK-MEL-5)	[2]
Sorafenib + Terameprocol	DCX4ZVB	Sorafenib	Glioblastoma (Cell Line: SNB-75)	[2]
Sorafenib + Terameprocol	DCDJ7CF	Sorafenib	Glioma (Cell Line: SF-539)	[2]
Sorafenib + Terameprocol	DCZD0EF	Sorafenib	Glioma (Cell Line: SF-268)	[2]
Sorafenib + Terameprocol	DCP2ZIJ	Sorafenib	Glioma (Cell Line: SF-295)	[2]
Sorafenib + Terameprocol	DCXBOGY	Sorafenib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[2]
Sorafenib + Terameprocol	DCTGWDG	Sorafenib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[2]
Sorafenib + Terameprocol	DCR8OR5	Sorafenib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[2]
Sorafenib + Terameprocol	DCIXI1K	Sorafenib	Lung adenocarcinoma (Cell Line: EKVX)	[2]
Sorafenib + Terameprocol	DCU8S0N	Sorafenib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[2]
Sorafenib + Terameprocol	DCIRYWP	Sorafenib	Lung adenocarcinoma (Cell Line: HOP-62)	[2]
Sorafenib + Terameprocol	DCQ2WQS	Sorafenib	Lung adenocarcinoma (Cell Line: NCI-H522)	[2]
Sorafenib + Terameprocol	DCRU7SD	Sorafenib	Malignant melanoma (Cell Line: UACC62)	[2]
Sorafenib + Terameprocol	DCEWZPX	Sorafenib	Malignant melanoma (Cell Line: LOX IMVI)	[2]
Sorafenib + Terameprocol	DCNVRVQ	Sorafenib	Melanoma (Cell Line: MALME-3M)	[2]
Sorafenib + Terameprocol	DCRL79O	Sorafenib	Melanoma (Cell Line: UACC-257)	[2]
Sorafenib + Terameprocol	DCJ61SL	Sorafenib	Melanoma (Cell Line: SK-MEL-2)	[2]
Sorafenib + Terameprocol	DC4YX6G	Sorafenib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[2]
Sorafenib + Terameprocol	DCJV308	Sorafenib	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Sorafenib + Terameprocol	DCTCJA5	Sorafenib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[2]
Sorafenib + Terameprocol	DCXZ74U	Sorafenib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[3]
Sorafenib + Terameprocol	DC59M98	Sorafenib	Colon carcinoma (Cell Line: KM12)	[3]
Sorafenib + Terameprocol	DCPWVIL	Sorafenib	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Sorafenib + Terameprocol	DC67Q5H	Sorafenib	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Sorafenib + Terameprocol	DCK8ZC0	Sorafenib	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Sulfapyridine + Terameprocol	DCSY00D	Sulfapyridine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
SY-1425 + Terameprocol	DCUU5KG	SY-1425	Astrocytoma (Cell Line: SNB-19)	[2]
SY-1425 + Terameprocol	DCUQWIC	SY-1425	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
SY-1425 + Terameprocol	DCHTK01	SY-1425	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
SY-1425 + Terameprocol	DCWDG2S	SY-1425	Glioma (Cell Line: SF-295)	[2]
SY-1425 + Terameprocol	DC3O9QK	SY-1425	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
SY-1425 + Terameprocol	DCI4FN3	SY-1425	Renal cell carcinoma (Cell Line: UO-31)	[2]
SY-1425 + Terameprocol	DCKS5JY	SY-1425	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
SY-1425 + Terameprocol	DCSN8T0	SY-1425	Adenocarcinoma (Cell Line: NCIH23)	[4]
SY-1425 + Terameprocol	DCE49JO	SY-1425	Adenocarcinoma (Cell Line: HCT116)	[4]
SY-1425 + Terameprocol	DCAYAR2	SY-1425	Adenocarcinoma (Cell Line: HCT-15)	[4]
SY-1425 + Terameprocol	DC9OIZJ	SY-1425	Adenocarcinoma (Cell Line: SW-620)	[4]
SY-1425 + Terameprocol	DCK9XX9	SY-1425	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
SY-1425 + Terameprocol	DCSFEFK	SY-1425	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
SY-1425 + Terameprocol	DC9AKQ7	SY-1425	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[4]
SY-1425 + Terameprocol	DCTGDSH	SY-1425	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
SY-1425 + Terameprocol	DCN4GSL	SY-1425	Prostate carcinoma (Cell Line: PC-3)	[4]
Taxol + Terameprocol	DC08I6Q	Taxol	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Taxol + Terameprocol	DC3PRJN	Taxol	Glioma (Cell Line: SF-539)	[2]
Taxol + Terameprocol	DCXUVF3	Taxol	Colon carcinoma (Cell Line: KM12)	[3]
Taxol + Terameprocol	DCLGICU	Taxol	Adenocarcinoma (Cell Line: SW-620)	[4]
Taxol + Terameprocol	DCLOXKP	Taxol	Adenocarcinoma (Cell Line: HCT-15)	[4]
Taxol + Terameprocol	DCCO45P	Taxol	Amelanotic melanoma (Cell Line: M14)	[4]
Taxol + Terameprocol	DCJ0S70	Taxol	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
Terameprocol + Aprepitant	DC424FF	Aprepitant	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Ribavirin-TP	DCVDTUG	Ribavirin-TP	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Lefaxin	DCT3O9S	Lefaxin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Pentostatin	DCXOWQU	Pentostatin	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Terameprocol + Pentostatin	DCHEVWW	Pentostatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Pentostatin	DC6TCQB	Pentostatin	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Terameprocol + Pentostatin	DCZ0S6X	Pentostatin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Terameprocol + Bepridil	DCOZ00Z	Bepridil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Fulvestrant	DC065BH	Fulvestrant	Glioblastoma (Cell Line: SNB-75)	[2]
Terameprocol + Gefitinib	DC1H55W	Gefitinib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Acetazolamide	DCPJKNR	Acetazolamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Citalopram	DC3VFZF	Citalopram	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Crotamiton	DCTMXIG	Crotamiton	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Terazosin	DCFLUJO	Terazosin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + GYKI-52466	DCVAQWO	GYKI-52466	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Cyclophosphamide	DC29E5E	Cyclophosphamide	Glioma (Cell Line: SF-539)	[2]
Terameprocol + Cyclophosphamide	DC6HCXC	Cyclophosphamide	Renal cell carcinoma (Cell Line: UO-31)	[2]
Terameprocol + Tacrine	DC23Y8A	Tacrine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Panobinostat	DCA9YAY	Panobinostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[2]
Terameprocol + Methotrexate	DCYKBBC	Methotrexate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Isoniazid	DCCRWSG	Isoniazid	Glioma (Cell Line: SF-268)	[2]
Terameprocol + Plicamycin	DCFMKQ0	Plicamycin	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Terameprocol + Plicamycin	DCGMU0I	Plicamycin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Terameprocol + Plicamycin	DCNGR58	Plicamycin	Renal cell carcinoma (Cell Line: SN12C)	[2]
Terameprocol + Nilotinib	DCO7VA9	Nilotinib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Terameprocol + Nilotinib	DCP4CSY	Nilotinib	Renal cell carcinoma (Cell Line: SN12C)	[2]
Terameprocol + Everolimus	DCMAPY8	Everolimus	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Pepstatin	DCXHWGA	Pepstatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + IT-141	DC15PEO	IT-141	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Pamidronate	DCZA34V	Pamidronate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Methylergonovine	DC09H55	Methylergonovine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Emetine	DCJH0IX	Emetine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Ifosfamide	DCC6J52	Ifosfamide	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Terameprocol + Doxapram	DCHIEMZ	Doxapram	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + K-134	DC9TFCJ	K-134	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Metformin	DCE1BA9	Metformin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Raloxifene	DCMDNPU	Raloxifene	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Terameprocol + Cilastatin	DCQZ17G	Cilastatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Sulfinpyrazone	DC3KPP1	Sulfinpyrazone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Bendamustine hydrochloride	DCEBZGK	Bendamustine hydrochloride	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Terameprocol + VR-776	DC7JCY2	VR-776	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Nizatidine	DCGF1W9	Nizatidine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Sirolimus	DCQOQM3	Sirolimus	Astrocytoma (Cell Line: U251)	[2]
Terameprocol + Sirolimus	DCE0S6Y	Sirolimus	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Terameprocol + Sirolimus	DCJFIHB	Sirolimus	Clear cell renal cell carcinoma (Cell Line: TK-10)	[2]
Terameprocol + Sirolimus	DCQRKBN	Sirolimus	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Terameprocol + Sirolimus	DC6A2KO	Sirolimus	Glioma (Cell Line: SF-539)	[2]
Terameprocol + Sirolimus	DCXJONC	Sirolimus	Glioma (Cell Line: SF-295)	[2]
Terameprocol + Sirolimus	DCIGCS2	Sirolimus	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Terameprocol + Mitomycin	DC93AIR	Mitomycin	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Terameprocol + Mitomycin	DCX20BX	Mitomycin	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Terameprocol + Mitomycin	DC0LFCZ	Mitomycin	Renal cell carcinoma (Cell Line: SN12C)	[2]
Terameprocol + Naringenin	DCB0YL1	Naringenin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Tolazoline	DCVH1IJ	Tolazoline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Arfolitixorin	DCUT50K	Arfolitixorin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + PF-02545920	DC5EUIN	PF-02545920	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Trazodone	DCHDYPZ	Trazodone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Isoproterenol	DCMZWCF	Isoproterenol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Trifluoperazine	DC33OSM	Trifluoperazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Altretamine	DC10R5C	Altretamine	Astrocytoma (Cell Line: U251)	[2]
Terameprocol + Altretamine	DCVPFDW	Altretamine	Clear cell renal cell carcinoma (Cell Line: TK-10)	[2]
Terameprocol + Altretamine	DCGZ6PC	Altretamine	Glioma (Cell Line: SF-295)	[2]
Terameprocol + Altretamine	DC3GD3Z	Altretamine	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Terameprocol + Entacapone	DCO9SK3	Entacapone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + TEM	DCQ9Q5Y	TEM	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Terameprocol + TEM	DCZX1B5	TEM	Renal cell carcinoma (Cell Line: UO-31)	[2]
Terameprocol + TEM	DCTLQYJ	TEM	Renal cell carcinoma (Cell Line: SN12C)	[2]
Terameprocol + Pargyline	DCIM75I	Pargyline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Methocarbamol	DCFWBWR	Methocarbamol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Imatinib	DC8MUI5	Imatinib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Darunavir	DCYMOMF	Darunavir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Atenolol	DCFVAJ2	Atenolol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Methylene blue	DCYDA8N	Methylene blue	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Moricizine	DCT89BM	Moricizine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Enalaprilat	DC28QSR	Enalaprilat	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Maprotiline	DCHYVGH	Maprotiline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Oxyphenbutazone	DCI0GSS	Oxyphenbutazone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Leflunomide	DCTH50F	Leflunomide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + ER819762	DCHG4CL	ER819762	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Terameprocol + Asenapine	DC16PWQ	Asenapine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Pomalidomide	DC5D3RS	Pomalidomide	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Terameprocol + Pomalidomide	DC6196F	Pomalidomide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Pomalidomide	DCM8X5L	Pomalidomide	Glioma (Cell Line: SF-295)	[2]
Terameprocol + Pomalidomide	DCU5FW8	Pomalidomide	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Terameprocol + Endoxifen	DCM6RGO	Endoxifen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Hydralazine	DCLPLYY	Hydralazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Fosfomycin	DCBDHM5	Fosfomycin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Doxorubicin	DC869VC	Doxorubicin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Zileuton	DCULT0V	Zileuton	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Auranofin	DCPCSO3	Auranofin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + PMID28870136-Compound-43	DCARBDI	PMID28870136-Compound-43	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Terameprocol + PMID28870136-Compound-43	DC2O9YM	PMID28870136-Compound-43	Astrocytoma (Cell Line: U251)	[2]
Terameprocol + PMID28870136-Compound-43	DC266YO	PMID28870136-Compound-43	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + FORMESTANE	DCI7XJI	FORMESTANE	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Terameprocol + FORMESTANE	DCDK4FE	FORMESTANE	Astrocytoma (Cell Line: U251)	[2]
Terameprocol + FORMESTANE	DCQ06SU	FORMESTANE	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Terameprocol + FORMESTANE	DCMXN65	FORMESTANE	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Terameprocol + FORMESTANE	DC4CMM2	FORMESTANE	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Terameprocol + FORMESTANE	DCBT0OR	FORMESTANE	Glioma (Cell Line: SF-295)	[2]
Terameprocol + FORMESTANE	DCI323K	FORMESTANE	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Terameprocol + Vorinostat	DCNZBCH	Vorinostat	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Cerivastatin	DCBY8OC	Cerivastatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Busulfan	DCGJO43	Busulfan	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Terameprocol + Busulfan	DC7X2NV	Busulfan	Astrocytoma (Cell Line: U251)	[2]
Terameprocol + Hydroxychloroquine	DCCPHGL	Hydroxychloroquine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Cytarabine	DC5MLSH	Cytarabine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Terameprocol + Pentostatin	DCPK9J5	Pentostatin	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Terameprocol + Fulvestrant	DCTRYUH	Fulvestrant	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[3]
Terameprocol + Hepzato	DCZJH4X	Hepzato	Carcinoma (Cell Line: MCF7)	[3]
Terameprocol + Hepzato	DCX18VR	Hepzato	Colon carcinoma (Cell Line: KM12)	[3]
Terameprocol + Cyclophosphamide	DCQDNS4	Cyclophosphamide	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Terameprocol + Plicamycin	DCFG3ZG	Plicamycin	Carcinoma (Cell Line: RXF 393)	[3]
Terameprocol + Plicamycin	DC6SICZ	Plicamycin	Colon carcinoma (Cell Line: KM12)	[3]
Terameprocol + Plicamycin	DC5TS2A	Plicamycin	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Terameprocol + Nilotinib	DCJ2XTD	Nilotinib	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Terameprocol + Ifosfamide	DCM9N2R	Ifosfamide	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[3]
Terameprocol + Ifosfamide	DCRS9K4	Ifosfamide	Colon carcinoma (Cell Line: KM12)	[3]
Terameprocol + Ifosfamide	DCJO8MN	Ifosfamide	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Terameprocol + Sirolimus	DC738Y5	Sirolimus	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[3]
Terameprocol + Sirolimus	DCS3T3G	Sirolimus	Colon carcinoma (Cell Line: KM12)	[3]
Terameprocol + Sirolimus	DCZQKB4	Sirolimus	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Terameprocol + Altretamine	DCMGCIZ	Altretamine	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Terameprocol + Altretamine	DCPGIK7	Altretamine	Colon carcinoma (Cell Line: KM12)	[3]
Terameprocol + Altretamine	DCSCSH4	Altretamine	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Terameprocol + Chlorambucil	DC8F6IM	Chlorambucil	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Terameprocol + Pomalidomide	DC0GZB5	Pomalidomide	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[3]
Terameprocol + Pomalidomide	DCN9GNV	Pomalidomide	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Terameprocol + Pomalidomide	DC7R7YH	Pomalidomide	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Terameprocol + Mepacrine	DCSAROC	Mepacrine	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Terameprocol + PMID28870136-Compound-43	DCZI23M	PMID28870136-Compound-43	Carcinoma (Cell Line: RXF 393)	[3]
Terameprocol + PMID28870136-Compound-43	DC18G50	PMID28870136-Compound-43	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Terameprocol + FORMESTANE	DCZW91A	FORMESTANE	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Terameprocol + Busulfan	DCZ5T9J	Busulfan	Colon carcinoma (Cell Line: KM12)	[3]
Terameprocol + Busulfan	DCJ3BJY	Busulfan	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Terameprocol + Pentostatin	DC762M3	Pentostatin	Adenocarcinoma (Cell Line: SW-620)	[4]
Terameprocol + Pentostatin	DCYWCHE	Pentostatin	Adenocarcinoma (Cell Line: HCT-15)	[4]
Terameprocol + Pentostatin	DCZXTUL	Pentostatin	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
Terameprocol + Fulvestrant	DC24LZN	Fulvestrant	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[4]
Terameprocol + Fulvestrant	DC8XQBZ	Fulvestrant	Malignant melanoma (Cell Line: LOX IMVI)	[4]
Terameprocol + Hepzato	DCA5K55	Hepzato	Adenocarcinoma (Cell Line: DU-145)	[4]
Terameprocol + Hepzato	DCO7ED3	Hepzato	Adenocarcinoma (Cell Line: A549)	[4]
Terameprocol + Hepzato	DCY48LA	Hepzato	Lung adenocarcinoma (Cell Line: NCI-H522)	[4]
Terameprocol + Cyclophosphamide	DCUPTGJ	Cyclophosphamide	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Terameprocol + Cyclophosphamide	DC4KE3F	Cyclophosphamide	Adenocarcinoma (Cell Line: HCT116)	[4]
Terameprocol + Cyclophosphamide	DCL35Z6	Cyclophosphamide	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[4]
Terameprocol + Cyclophosphamide	DCGMVHH	Cyclophosphamide	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
Terameprocol + Cyclophosphamide	DCRIKM8	Cyclophosphamide	Malignant melanoma (Cell Line: UACC62)	[4]
Terameprocol + Isoniazid	DCBOY3W	Isoniazid	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Terameprocol + Isoniazid	DCHL6R9	Isoniazid	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Terameprocol + Isoniazid	DCGUF3M	Isoniazid	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Terameprocol + Arsenic trioxide	DCUPFE5	Arsenic trioxide	Adenocarcinoma (Cell Line: HCT116)	[4]
Terameprocol + Arsenic trioxide	DCGYSTW	Arsenic trioxide	Melanoma (Cell Line: MALME-3M)	[4]
Terameprocol + Plicamycin	DC8N6HM	Plicamycin	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Terameprocol + Plicamycin	DCNO67S	Plicamycin	Adenocarcinoma (Cell Line: A549)	[4]
Terameprocol + Plicamycin	DCA1X0C	Plicamycin	Adenocarcinoma (Cell Line: HCT116)	[4]
Terameprocol + Plicamycin	DCHQQ2D	Plicamycin	Adenocarcinoma (Cell Line: SW-620)	[4]
Terameprocol + Plicamycin	DCIOUEH	Plicamycin	Adenocarcinoma (Cell Line: HT29)	[4]
Terameprocol + Plicamycin	DCRB2WP	Plicamycin	Amelanotic melanoma (Cell Line: M14)	[4]
Terameprocol + Plicamycin	DCV1IUB	Plicamycin	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Terameprocol + Plicamycin	DCC4DMF	Plicamycin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Terameprocol + Plicamycin	DCQLD62	Plicamycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Terameprocol + Plicamycin	DC1A1MT	Plicamycin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Terameprocol + Plicamycin	DCYV82U	Plicamycin	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
Terameprocol + Plicamycin	DCE0FSS	Plicamycin	Lung adenocarcinoma (Cell Line: HOP-62)	[4]
Terameprocol + Plicamycin	DCB2T51	Plicamycin	Malignant melanoma (Cell Line: UACC62)	[4]
Terameprocol + Plicamycin	DCCLIO4	Plicamycin	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Terameprocol + Plicamycin	DCRYMVF	Plicamycin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[4]
Terameprocol + Plicamycin	DCRH23D	Plicamycin	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[4]
Terameprocol + Ifosfamide	DCG9E3S	Ifosfamide	Adenocarcinoma (Cell Line: DU-145)	[4]
Terameprocol + Ifosfamide	DCDYE5Z	Ifosfamide	Adenocarcinoma (Cell Line: HT29)	[4]
Terameprocol + Ifosfamide	DC4BKAL	Ifosfamide	Adenocarcinoma (Cell Line: HCT116)	[4]
Terameprocol + Ifosfamide	DC4G5IS	Ifosfamide	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Terameprocol + Ifosfamide	DCFG0AX	Ifosfamide	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Terameprocol + Ifosfamide	DCTNE7S	Ifosfamide	Malignant melanoma (Cell Line: UACC62)	[4]
Terameprocol + Ifosfamide	DC54HU0	Ifosfamide	Malignant melanoma (Cell Line: LOX IMVI)	[4]
Terameprocol + Ifosfamide	DCFEYMI	Ifosfamide	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[4]
Terameprocol + Ifosfamide	DCVL3ST	Ifosfamide	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Terameprocol + Raloxifene	DCP6HCQ	Raloxifene	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Terameprocol + Sirolimus	DCI81PE	Sirolimus	Adenocarcinoma (Cell Line: HCT116)	[4]
Terameprocol + Sirolimus	DCDBVY7	Sirolimus	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Terameprocol + Sirolimus	DC4J52P	Sirolimus	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
Terameprocol + Sirolimus	DCHKN0L	Sirolimus	Lung adenocarcinoma (Cell Line: EKVX)	[4]
Terameprocol + Sirolimus	DCRRST1	Sirolimus	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[4]
Terameprocol + Sirolimus	DCSMHQ0	Sirolimus	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[4]
Terameprocol + Mitomycin	DCTZIC4	Mitomycin	Adenocarcinoma (Cell Line: DU-145)	[4]
Terameprocol + Mitomycin	DCQMCWM	Mitomycin	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Terameprocol + Mitomycin	DCIGM1C	Mitomycin	Adenocarcinoma (Cell Line: A549)	[4]
Terameprocol + Mitomycin	DCIYWBU	Mitomycin	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Terameprocol + Mitomycin	DCGHHUO	Mitomycin	Adenocarcinoma (Cell Line: HT29)	[4]
Terameprocol + Mitomycin	DCTZ0U1	Mitomycin	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Terameprocol + Mitomycin	DC8C74C	Mitomycin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Terameprocol + Altretamine	DC310HB	Altretamine	Adenocarcinoma (Cell Line: DU-145)	[4]
Terameprocol + Altretamine	DC4DR58	Altretamine	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Terameprocol + Altretamine	DCBBWR5	Altretamine	Adenocarcinoma (Cell Line: A549)	[4]
Terameprocol + Altretamine	DC8O5AX	Altretamine	Adenocarcinoma (Cell Line: HCT116)	[4]
Terameprocol + Altretamine	DCJ7WYC	Altretamine	Melanoma (Cell Line: UACC-257)	[4]
Terameprocol + Altretamine	DCRWVOO	Altretamine	Melanoma (Cell Line: MALME-3M)	[4]
Terameprocol + Altretamine	DCXJV1N	Altretamine	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Terameprocol + TEM	DC3M1JX	TEM	Melanoma (Cell Line: SK-MEL-2)	[4]
Terameprocol + Cisplatin	DCIH05X	Cisplatin	Adenocarcinoma (Cell Line: HCT116)	[4]
Terameprocol + Chlorambucil	DC505UL	Chlorambucil	Adenocarcinoma (Cell Line: HCT-15)	[4]
Terameprocol + Chlorambucil	DCILGKY	Chlorambucil	Adenocarcinoma (Cell Line: HT29)	[4]
Terameprocol + ER819762	DCOL785	ER819762	Adenocarcinoma (Cell Line: HCT116)	[4]
Terameprocol + ER819762	DCA9JFT	ER819762	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Terameprocol + ER819762	DCX5L99	ER819762	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Terameprocol + ER819762	DCHDIDP	ER819762	Melanoma (Cell Line: MALME-3M)	[4]
Terameprocol + ER819762	DCFH9LK	ER819762	Melanoma (Cell Line: UACC-257)	[4]
Terameprocol + ER819762	DCHOTXW	ER819762	Prostate carcinoma (Cell Line: PC-3)	[4]
Terameprocol + Pomalidomide	DC0DKCT	Pomalidomide	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Terameprocol + Pomalidomide	DCPC80A	Pomalidomide	Adenocarcinoma (Cell Line: HCT116)	[4]
Terameprocol + Pomalidomide	DCFQ23H	Pomalidomide	Adenocarcinoma (Cell Line: HT29)	[4]
Terameprocol + Pomalidomide	DCI7CN6	Pomalidomide	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Terameprocol + Pomalidomide	DCT3L6S	Pomalidomide	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Terameprocol + Pomalidomide	DCARGR9	Pomalidomide	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Terameprocol + Pomalidomide	DCFK5YD	Pomalidomide	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
Terameprocol + Pomalidomide	DC5U30V	Pomalidomide	Lung adenocarcinoma (Cell Line: EKVX)	[4]
Terameprocol + Pomalidomide	DCXAG8C	Pomalidomide	Malignant melanoma (Cell Line: UACC62)	[4]
Terameprocol + Pomalidomide	DCXZXCR	Pomalidomide	Melanoma (Cell Line: MALME-3M)	[4]
Terameprocol + Pomalidomide	DCQZO27	Pomalidomide	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Terameprocol + Pomalidomide	DCBA0QB	Pomalidomide	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[4]
Terameprocol + Mepacrine	DCH0IAT	Mepacrine	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Terameprocol + Mepacrine	DCQM36H	Mepacrine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[4]
Terameprocol + Mepacrine	DC0L9VF	Mepacrine	Malignant melanoma (Cell Line: UACC62)	[4]
Terameprocol + PMID28870136-Compound-43	DCKRQE7	PMID28870136-Compound-43	Adenocarcinoma (Cell Line: DU-145)	[4]
Terameprocol + PMID28870136-Compound-43	DCT1UVP	PMID28870136-Compound-43	Adenocarcinoma (Cell Line: HT29)	[4]
Terameprocol + PMID28870136-Compound-43	DCFY7QN	PMID28870136-Compound-43	Melanoma (Cell Line: MALME-3M)	[4]
Terameprocol + FORMESTANE	DCQ5KCF	FORMESTANE	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Terameprocol + FORMESTANE	DCTGLTL	FORMESTANE	Adenocarcinoma (Cell Line: HCT116)	[4]
Terameprocol + FORMESTANE	DCQEH2M	FORMESTANE	Adenocarcinoma (Cell Line: SW-620)	[4]
Terameprocol + FORMESTANE	DC23I9R	FORMESTANE	Adenocarcinoma (Cell Line: HT29)	[4]
Terameprocol + FORMESTANE	DCU7YSO	FORMESTANE	Amelanotic melanoma (Cell Line: M14)	[4]
Terameprocol + FORMESTANE	DCQ01SW	FORMESTANE	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Terameprocol + FORMESTANE	DCOY3T3	FORMESTANE	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Terameprocol + FORMESTANE	DCCH7JN	FORMESTANE	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
Terameprocol + FORMESTANE	DCUOXAK	FORMESTANE	Malignant melanoma (Cell Line: UACC62)	[4]
Terameprocol + FORMESTANE	DCP5MTL	FORMESTANE	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Terameprocol + FORMESTANE	DCCJYXM	FORMESTANE	Prostate carcinoma (Cell Line: PC-3)	[4]
Terameprocol + Aminolevulinic Acid Hydrochloride	DCY7GDV	Aminolevulinic Acid Hydrochloride	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Terameprocol + Busulfan	DC779ZC	Busulfan	Adenocarcinoma (Cell Line: DU-145)	[4]
Terameprocol + Busulfan	DC6F020	Busulfan	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Terameprocol + Busulfan	DC8XGP3	Busulfan	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[4]
Terameprocol + Busulfan	DCPSS7J	Busulfan	Lung adenocarcinoma (Cell Line: HOP-62)	[4]
Testosterone cypionate + Terameprocol	DCIE9ZB	Testosterone cypionate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Tetracycline + Terameprocol	DCSY88G	Tetracycline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Thioguanine + Terameprocol	DC76TBJ	Thioguanine	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Topotecan + Terameprocol	DCB2JJN	Topotecan	Carcinoma (Cell Line: MCF7)	[3]
Topotecan + Terameprocol	DCRX4AG	Topotecan	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Topotecan + Terameprocol	DC1B4DJ	Topotecan	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Topotecan + Terameprocol	DCU7FJ5	Topotecan	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Topotecan + Terameprocol	DC7KF4D	Topotecan	Clear cell renal cell carcinoma (Cell Line: TK-10)	[4]
Topotecan + Terameprocol	DCHH52G	Topotecan	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[4]
Topotecan + Terameprocol	DCEN9PL	Topotecan	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Topotecan + Terameprocol	DCZRX3H	Topotecan	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Topotecan + Terameprocol	DCUYPYL	Topotecan	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[4]
Topotecan + Terameprocol	DC1MC3E	Topotecan	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Topotecan + Terameprocol	DCFL2XL	Topotecan	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[4]
Triapine + Terameprocol	DCRGSRI	Triapine	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Triapine + Terameprocol	DC14U6X	Triapine	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Triapine + Terameprocol	DCENA0I	Triapine	Adenocarcinoma (Cell Line: SW-620)	[4]
Triapine + Terameprocol	DCM0U5R	Triapine	Glioma (Cell Line: SF-539)	[4]
Triapine + Terameprocol	DCAXD3H	Triapine	Glioma (Cell Line: SF-268)	[4]
Triapine + Terameprocol	DCWKNSF	Triapine	Papillary renal cell carcinoma (Cell Line: ACHN)	[4]
Triflupromazine + Terameprocol	DCWRAB1	Triflupromazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Trifluridine + Terameprocol	DCRYNG8	Trifluridine	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[3]
Trifluridine + Terameprocol	DCVL2L2	Trifluridine	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Trifluridine + Terameprocol	DCJ8K5K	Trifluridine	Adenocarcinoma (Cell Line: NCIH23)	[4]
Trifluridine + Terameprocol	DCA4DR4	Trifluridine	Adenocarcinoma (Cell Line: HCT116)	[4]
Trihexyphenidyl + Terameprocol	DC0WWKQ	Trihexyphenidyl	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Trimethobenzamide + Terameprocol	DCGZZN7	Trimethobenzamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Trioxsalen + Terameprocol	DCZS0N0	Trioxsalen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Uracil mustard + Terameprocol	DC583VM	Uracil mustard	Astrocytoma (Cell Line: SNB-19)	[2]
Uracil mustard + Terameprocol	DCI1P6F	Uracil mustard	Adenocarcinoma (Cell Line: HCT116)	[4]
Uracil mustard + Terameprocol	DCGYGWT	Uracil mustard	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Ursodeoxycholic acid + Terameprocol	DCWKT97	Ursodeoxycholic acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Valproic Acid + Terameprocol	DCUXI9L	Valproic Acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Vandetanib + Terameprocol	DCTW40Q	Vandetanib	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Vandetanib + Terameprocol	DC8ZNPZ	Vandetanib	Colon carcinoma (Cell Line: KM12)	[3]
Vandetanib + Terameprocol	DCJL25C	Vandetanib	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Vandetanib + Terameprocol	DCDSV79	Vandetanib	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Vandetanib + Terameprocol	DCPZ87G	Vandetanib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Vandetanib + Terameprocol	DCINSQ4	Vandetanib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Vandetanib + Terameprocol	DC2EYRB	Vandetanib	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Vandetanib + Terameprocol	DCFKAGU	Vandetanib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[4]
Vandetanib + Terameprocol	DC66YTU	Vandetanib	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Vandetanib + Terameprocol	DCEH60K	Vandetanib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Vandetanib + Terameprocol	DCTGNHR	Vandetanib	Glioma (Cell Line: SF-268)	[4]
Vandetanib + Terameprocol	DCZ748W	Vandetanib	Melanoma (Cell Line: SK-MEL-2)	[4]
Vandetanib + Terameprocol	DCCXAN8	Vandetanib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
Vandetanib + Terameprocol	DCLO9Y4	Vandetanib	Plasma cell myeloma (Cell Line: RPMI-8226)	[4]
Vemurafenib + Terameprocol	DC6RUMA	Vemurafenib	Carcinoma (Cell Line: MCF7)	[3]
Vemurafenib + Terameprocol	DC6Y6IU	Vemurafenib	Colon carcinoma (Cell Line: KM12)	[3]
Vemurafenib + Terameprocol	DCY6P8D	Vemurafenib	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Vemurafenib + Terameprocol	DCX50SK	Vemurafenib	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Vemurafenib + Terameprocol	DCRQR3H	Vemurafenib	Adenocarcinoma (Cell Line: DU-145)	[4]
Vemurafenib + Terameprocol	DCLE032	Vemurafenib	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Vemurafenib + Terameprocol	DCJEAXE	Vemurafenib	Adenocarcinoma (Cell Line: NCIH23)	[4]
Vemurafenib + Terameprocol	DCWZDJQ	Vemurafenib	Adenocarcinoma (Cell Line: HCT-15)	[4]
Vemurafenib + Terameprocol	DCXMIGI	Vemurafenib	Adenocarcinoma (Cell Line: HCT116)	[4]
Vemurafenib + Terameprocol	DCM9RZ0	Vemurafenib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Vemurafenib + Terameprocol	DCNXUP5	Vemurafenib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Vemurafenib + Terameprocol	DCZDZK9	Vemurafenib	Glioblastoma (Cell Line: SNB-75)	[4]
Vemurafenib + Terameprocol	DCIU4WO	Vemurafenib	Glioma (Cell Line: SF-268)	[4]
Vemurafenib + Terameprocol	DCXHJG4	Vemurafenib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Vemurafenib + Terameprocol	DC0UZ9T	Vemurafenib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[4]
Vemurafenib + Terameprocol	DCIZWUD	Vemurafenib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Vemurafenib + Terameprocol	DCQXBOS	Vemurafenib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[4]
Vemurafenib + Terameprocol	DCCANZU	Vemurafenib	Lung adenocarcinoma (Cell Line: EKVX)	[4]
Vemurafenib + Terameprocol	DCZO15L	Vemurafenib	Lung adenocarcinoma (Cell Line: NCI-H522)	[4]
Vemurafenib + Terameprocol	DC3GULW	Vemurafenib	Melanoma (Cell Line: SK-MEL-2)	[4]
Vemurafenib + Terameprocol	DC5YRXJ	Vemurafenib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
Vemurafenib + Terameprocol	DCUZN1R	Vemurafenib	Prostate carcinoma (Cell Line: PC-3)	[4]
Vemurafenib + Terameprocol	DCRNDL8	Vemurafenib	Renal cell carcinoma (Cell Line: SN12C)	[4]
Vinflunine + Terameprocol	DC0KM44	Vinflunine	Colon adenocarcinoma (Cell Line: COLO 205)	[3]
Vinflunine + Terameprocol	DC7YALS	Vinflunine	Colon carcinoma (Cell Line: KM12)	[3]
Vinflunine + Terameprocol	DCMFIL2	Vinflunine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Vismodegib + Terameprocol	DC361XE	Vismodegib	Carcinoma (Cell Line: MCF7)	[3]
Vismodegib + Terameprocol	DC9DISQ	Vismodegib	Colon carcinoma (Cell Line: KM12)	[3]
Vismodegib + Terameprocol	DCST5K0	Vismodegib	Invasive ductal carcinoma (Cell Line: HS 578T)	[3]
Vismodegib + Terameprocol	DC1MEXT	Vismodegib	Invasive ductal carcinoma (Cell Line: T-47D)	[3]
Vismodegib + Terameprocol	DCXX37W	Vismodegib	Invasive ductal carcinoma (Cell Line: BT-549)	[3]
Vismodegib + Terameprocol	DC3RI20	Vismodegib	Adenocarcinoma (Cell Line: DU-145)	[4]
Vismodegib + Terameprocol	DCI42EZ	Vismodegib	Adenocarcinoma (Cell Line: HT29)	[4]
Vismodegib + Terameprocol	DC2PA52	Vismodegib	Adenocarcinoma (Cell Line: SW-620)	[4]
Vismodegib + Terameprocol	DCJHU2U	Vismodegib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Vismodegib + Terameprocol	DCH8WYK	Vismodegib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Vismodegib + Terameprocol	DCLDAGO	Vismodegib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Vismodegib + Terameprocol	DCGPJZK	Vismodegib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[4]
Vismodegib + Terameprocol	DCFG497	Vismodegib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[4]
Vismodegib + Terameprocol	DCFM4TM	Vismodegib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Vismodegib + Terameprocol	DCG41JT	Vismodegib	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Vismodegib + Terameprocol	DCM136T	Vismodegib	Glioblastoma (Cell Line: SNB-75)	[4]
Vismodegib + Terameprocol	DCDEPTQ	Vismodegib	Glioma (Cell Line: SF-268)	[4]
Vismodegib + Terameprocol	DCFKVYS	Vismodegib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Vismodegib + Terameprocol	DCOXR15	Vismodegib	Lung adenocarcinoma (Cell Line: NCI-H522)	[4]
Vismodegib + Terameprocol	DC5WSB0	Vismodegib	Melanoma (Cell Line: SK-MEL-2)	[4]
Vismodegib + Terameprocol	DC2TNYJ	Vismodegib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[4]
Vismodegib + Terameprocol	DC2XP7I	Vismodegib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Vismodegib + Terameprocol	DCJC3MQ	Vismodegib	Papillary renal cell carcinoma (Cell Line: ACHN)	[4]
Vismodegib + Terameprocol	DCI2UET	Vismodegib	Plasma cell myeloma (Cell Line: RPMI-8226)	[4]
Vismodegib + Terameprocol	DCUKSWH	Vismodegib	Renal cell carcinoma (Cell Line: SN12C)	[4]
Zaleplon + Terameprocol	DC3BBUH	Zaleplon	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
------------------------------------------------------------------------------------


⏷ Show the Full List of 825 DrugCom(s)

References

1	Terameprocol, a novel site-specific transcription inhibitor with anticancer activity. IDrugs. 2008 Mar;11(3):204-14.
2	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3	Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
4	Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.